K-numberK250172
Device nameGreen Card Bowie-Dick Test (BD115)
ApplicantSteritec Products, Inc. (A Getinge Company)
Product codeJOJ
Device classClass II
Decision dateFeb 20, 2025
DecisionSubstantially Equivalent
Regulation880.2800
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Green Card Bowie-Dick Test is a sterilization process indicator card designed to detect residual air in pre-vacuum steam sterilizers operating at 270°F (132°C) and 273°F (134°C) for 3.5 minutes. The card changes color uniformly from purple to green when proper sterilization conditions are met with no air present; a non-uniform color change (purple remaining in center) indicates the presence of residual air.

Technological characteristics

The subject device is a 3.5" × 1.91" card (versus 3.5" × 1.85" for predicate) with indicator ink printed on one side and laminated with polyester film on both sides. The key modification is expansion of the intended use to include monitoring at 134°C for 3.5 minutes in addition to the predicate's 132°C cycle. The design, color change mechanism, interpretation criteria, shelf life (2 years), and holder assembly remain identical to the predicate device.

Test standards cited

ANSI/AAMI/ISO 11140-5 Sterilization of health care products — Chemical indicators Part 5: Class 2 indicators for Bowie and Dick-type air removal tests. Testing included Annex B (uniform color change), Annex F (non-uniform color change), Annex C (dry heat testing), and Annex A (color density).

Substantial equivalence argument

The subject device performs identically to the predicate in all functional aspects except for the addition of a single exposure condition (134°C for 3.5 minutes). Performance testing on three manufactured lots demonstrates the device meets all applicable ANSI/AAMI/ISO 11140-5 acceptance criteria for both pass and fail scenarios, with identical color change mechanisms, interpretation, and stability characteristics. The minor card dimension change (0.06 inches) and product name change do not affect functionality. Expansion to the higher temperature cycle does not introduce new safety or effectiveness concerns since the device uses the same indicator chemistry and operates on the same physical principles.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →